Results 191 to 200 of about 697,556 (384)
CLEARING FACTOR, A HEPARIN-ACTIVATED LIPOPROTEIN LIPASE
Edward D. Korn
openalex +1 more source
Heparin-like Anticoagulant Occuring in Association with Chronic Nephritis [PDF]
A I Cetingil, O.N. Ulutin, Meryem Karaca
openalex +1 more source
Pharmacology of Heparin and Related Drugs
B. Mulloy+4 more
semanticscholar +1 more source
An Engineered PfAgo with Wide Catalytic Temperature Range and Substrate Spectrum
This work presents a strategy for engineering thermophilic Ago proteins to obtain wide catalytic temperature range and broad substrate spectrum. This strategy is applied to engineer PfAgo and TtdAgo, and the biochemical properties of the engineered PfAgo are systematically characterized. The study further elucidates the structural differences involved.
Longyu Wang+11 more
wiley +1 more source
Studies of Fat Lipolysis by Post-Heparin Human Plasma Lipoprotein Lipase and by Human Pancreatic Lipase [PDF]
Hyman Engelberg
openalex +1 more source
Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients [PDF]
Banas, B.+3 more
core +1 more source
To maximize the efficacy of cancer vaccines, adjuvants, collection, lysis, purification, oxidation, loading sites, and sizes, etc., are investigated. The optimized cancer nanovaccines loading whole tumor antigens can cure all or most tumor‐bearing mice in multiple mouse cancer models.
Xiangxiang Xu+13 more
wiley +1 more source
Phosphate Contamination of Commercial Heparin [PDF]
Mary G. McGeown+2 more
openalex +1 more source
A highly efficient extracorporeal device for treating bacteremia is developed by integrating microfluidic bacterial margination and engineered cell‐depleted thrombi strategically constructed in the device. The rodent models, severely infected with antibiotic‐resistant bacteria, recover from bacteremia after two subsequent extracorporeal blood ...
Bong Hwan Jang+4 more
wiley +1 more source